Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1989-09-18
1991-06-18
Shen, Cecilia
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
558181, 560121, 560123, 560124, 560125, 560129, 560152, 560153, 560179, 560183, 560205, 560219, 560227, 562 24, C07F 938, C07F 940, A61K 3166
Patent
active
050250035
ABSTRACT:
Compounds which are inhibitors of cholesterol biosynthesis (by inhibiting de novo squalene biosynthetis), and thus are useful as hypocholesterolemic agents and antiatherosclerotic agents, are provided which have the structure ##STR1## wherein R.sup.2 is a metal ion, lower alkyl or H; R.sup.3 is a metal ion or lower alkyl;
REFERENCES:
patent: 3943201 (1976-03-01), McIntosh
patent: 4018854 (1977-04-01), McIntosh
patent: 4386081 (1983-05-01), Helgstrand et al.
Poulter, C. D., et al., Biosynthesis of Isoprenoid Compounds, "Conversion of Farnesyl Pyrophosphate to Squalene", vol. 1, Chapter 8, pp. 413-441, J. Wiley and Sons, 1981.
Faust, J. R., et al., Proc. Nat. Acad. Sci., U.S.A., "Squalene Synthetase Activity in Human Fibroblasts: Regulation via the Low Density Lipoprotein Receptor", 1979, 76, 5018-5022.
de Montellano, P. Ortiz, et al., J. Med. Chem., "Inhibition of Squalene Synthetase by Farnesyl Pyrophosphate Analogues", 1977, 20, 243-249.
Corey and Volante, J. Am. Chem. Soc. "Application of Unreactive Analogs of Terpenoid Pyrophosphates to Studies of Multistep Biosynthesis, Demonstration that `Presqualene Pyrophosphate` is an Essential Intermediate on the Path to Squalene", 1976, 98, 1291-3.
Sandifer, R. M. et al., J. Am. Chem. Soc., 1982, 104, 7376-8, "Squalene Synthetase, Inhibition by an Ammonium Analogue of a Carbocationic Intermediate in the Conversion of Presqualene Pyrophosphate to Squalene".
Bertolino, A., et al., Biochim. Biophys. Acta., 1978, 530, 17-23, "Polyisoprenoid Amphiphilic Compounds as Inhibitors of Squalene Synthesis and Other Microsomal Enzymes".
Davisson, F. J. et al., J. Org. Chem., 1986, 51, 4768-4779, "Phosporylation of Isoprenoid Alcohols".
Stremler, K. E. et al., J. A. C. S., 1987, 109, 5542, "Methane and Difluoromethanediphosphonate Analogues of Geranyl Diphosphate: Hydrolysis-Inert Alternate Substrates".
McClard, R. W., et al., J. Am. Chem. Soc., 1987, 109, 5544-5545, "Novel Phosphonylphosphinyl (P-C-P-C) Analogues of Biochemically Interesting Diphosphates, Syntheses and Properties of P-C-P-C Analogues of Isopentenyl Diphosphate and Dimethylallyl Diphosphate".
Capson, T. L., PhD Dissertation, Jun. 1987, Dept. of Medicinal Chemistry, the University of Utah, Abstract, Table of Contents, pp. 16, 17, 40-43, 48-51, Summary.
Biller, S. A. et al., J. Med. Chem., 1988, 31, 1869 "Isoprenoid(Phosphinylmethyl) Phosphonates as Inhibitors of Squalene Synthetase".
Merck Index, Tenth Edition, p. 607, Paragraph 4135.
Datlow Philip I.
E. R. Squibb & Sons Inc.
Rodney Burton
Shen Cecilia
LandOfFree
Isoprenoid phosphinylformic acid squalene synthetase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isoprenoid phosphinylformic acid squalene synthetase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isoprenoid phosphinylformic acid squalene synthetase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-145910